Skip to main content
Filing year 2024

THE PULMONARY HYPERTENSION

Washington, District of Columbia·EIN 65-0880021·NTEE G43 · Diseases, Disorders & Medical Disciplines·3
Total revenue
$8.5M
Total assets
$24.7M
Total expenses
$0
Reported officers
28
Mission

TO EXTEND AND IMPROVE THE LIVES OF THOSE AFFECTED BY PULMONARY HYPERTENSION (PH).

Executive compensation, broken down

Form 990 · Schedule J · 7 reported individuals · Filing year 2024

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
$330k
VP - Development
vice president
$182k
VP - Finance & Operations
vice president
$182k
VP - Quality Care & Research
vice president
$179k
VP - Advocacy & Patient Engagement
vice president
$166k
VP - Communications & Marketing
vice president
$163k
VP - Meetings (thru August)
vice president
$126k

Plus 21 unpaid individuals.

Browse compensation in Diseases, Disorders & Medical Disciplines

Up 6%
from 2023

From $312k in 2023 to $330k in 2024.

$312k
2023
$330k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.